[Therapeutic efficacy of a new antirheumatic agent with optimal gastrointestinal tolerance: 2-phenyl-4,p-chlorophenyl-thiazol-5-ilacetic acid (Fentiazac)]

Reumatismo. 1976 Jan-Mar;28(1):15-29.
[Article in Italian]
No abstract available

Publication types

  • English Abstract

MeSH terms

  • Acetates / adverse effects
  • Acetates / therapeutic use
  • Adult
  • Aged
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use*
  • Drug Evaluation
  • Drug Tolerance
  • Humans
  • Male
  • Middle Aged
  • Rheumatic Diseases / drug therapy*
  • Stomach / drug effects
  • Thiazoles / adverse effects
  • Thiazoles / therapeutic use*

Substances

  • Acetates
  • Anti-Inflammatory Agents
  • Thiazoles